These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 10760826

  • 1. Retinoic acid induces persistent, RARalpha-mediated anti-proliferative responses in Epstein-Barr virus-immortalized b lymphoblasts carrying an activated C-MYC oncogene but not in Burkitt's lymphoma cell lines.
    Cariati R, Zancai P, Quaia M, Cutrona G, Giannini F, Rizzo S, Boiocchi M, Dolcetti R.
    Int J Cancer; 2000 May 01; 86(3):375-84. PubMed ID: 10760826
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Retinoids irreversibly inhibit in vitro growth of Epstein-Barr virus-immortalized B lymphocytes.
    Pomponi F, Cariati R, Zancai P, De Paoli P, Rizzo S, Tedeschi RM, Pivetta B, De Vita S, Boiocchi M, Dolcetti R.
    Blood; 1996 Oct 15; 88(8):3147-59. PubMed ID: 8874215
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells.
    Barnouin K, Fredersdorf S, Eddaoudi A, Mittnacht S, Pan LX, Du MQ, Lu X.
    Oncogene; 1999 Nov 04; 18(46):6388-97. PubMed ID: 10597239
    [Abstract] [Full Text] [Related]

  • 7. Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts.
    Cutrona G, Ulivi M, Fais F, Roncella S, Ferrarini M.
    J Exp Med; 1995 Feb 01; 181(2):699-711. PubMed ID: 7836923
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.
    Jochner N, Eick D, Zimber-Strobl U, Pawlita M, Bornkamm GW, Kempkes B.
    EMBO J; 1996 Jan 15; 15(2):375-82. PubMed ID: 8617212
    [Abstract] [Full Text] [Related]

  • 10. Retinoic acid inhibits IL-6-dependent but not constitutive STAT3 activation in Epstein-Barr virus-immortalized B lymphocytes.
    Zancai P, Cariati R, Quaia M, Guidoboni M, Rizzo S, Boiocchi M, Dolcetti R.
    Int J Oncol; 2004 Aug 15; 25(2):345-55. PubMed ID: 15254731
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.
    Hsu SL, Hsu JW, Liu MC, Chen LY, Chang CD.
    Exp Cell Res; 2000 Aug 01; 258(2):322-31. PubMed ID: 10896783
    [Abstract] [Full Text] [Related]

  • 13. Retinoic acid-mediated growth inhibition of small cell lung cancer cells is associated with reduced myc and increased p27Kip1 expression.
    Weber E, Ravi RK, Knudsen ES, Williams JR, Dillehay LE, Nelkin BD, Kalemkerian GP, Feramisco JR, Mabry M.
    Int J Cancer; 1999 Mar 15; 80(6):935-43. PubMed ID: 10074929
    [Abstract] [Full Text] [Related]

  • 14. Reduced signal transduction through glucocorticoid receptor in Burkitt's lymphoma cell lines.
    Sinclair AJ, Jacquemin MG, Brooks L, Shanahan F, Brimmell M, Rowe M, Farrell PJ.
    Virology; 1994 Mar 15; 199(2):339-53. PubMed ID: 8122366
    [Abstract] [Full Text] [Related]

  • 15. Retinoic acid dramatically enhances the arsenic trioxide-induced cell cycle arrest and apoptosis in retinoic acid receptor alpha-positive human T-cell lymphotropic virus type-I-transformed cells.
    Darwiche N, El-Sabban M, Bazzi R, Nasr R, Al-Hashimi S, Hermine O, de Thé H, Bazarbachi A.
    Hematol J; 2001 Mar 15; 2(2):127-35. PubMed ID: 11424005
    [Abstract] [Full Text] [Related]

  • 16. c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.
    Faumont N, Durand-Panteix S, Schlee M, Grömminger S, Schuhmacher M, Hölzel M, Laux G, Mailhammer R, Rosenwald A, Staudt LM, Bornkamm GW, Feuillard J.
    J Virol; 2009 May 15; 83(10):5014-27. PubMed ID: 19264782
    [Abstract] [Full Text] [Related]

  • 17. Anti-IgM-mediated regulation of c-myc and its possible relationship to apoptosis.
    Kaptein JS, Lin CK, Wang CL, Nguyen TT, Kalunta CI, Park E, Chen FS, Lad PM.
    J Biol Chem; 1996 Aug 02; 271(31):18875-84. PubMed ID: 8702548
    [Abstract] [Full Text] [Related]

  • 18. Differential c-myc protein expression in Burkitt's lymphomas and EBV-transformed lymphoblastoid lines.
    Wennborg AD, Altiok E, Moore JP, Ernberg I, Klein G.
    Eur J Cancer; 1991 Aug 02; 27(12):1643-5. PubMed ID: 1782076
    [Abstract] [Full Text] [Related]

  • 19. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
    Wolf J, Pawlita M, Bullerdiek J, zur Hausen H.
    Cancer Res; 1990 May 15; 50(10):3095-100. PubMed ID: 2159373
    [Abstract] [Full Text] [Related]

  • 20. The effect pathway of retinoic acid through regulation of retinoic acid receptor alpha in gastric cancer cells.
    Liu S, Wu Q, Chen ZM, Su WJ.
    World J Gastroenterol; 2001 Oct 15; 7(5):662-6. PubMed ID: 11819850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.